Budget 2021 proposes to provide $59.2M to USask's VIDO, through Western Economic Diversification Canada’s Regional Economic Growth through Innovation program, to help it develop and manufacture bio-solutions such as vaccines and therapeutics.
Today the Government of Canada announced $59.2 million to VIDO to support the development of its vaccine candidates and the expansion of its research facilities, including a National Centre for Pandemic Research.
Three University of Saskatchewan researchers have been awarded a total of $1.87 million by the Canadian Institutes for Health Research (CIHR) for projects involving fatty liver disease, high blood pressure, and Zika virus.